Why Shares Of CureVac Are Trading Higher On Wednesday
CureVac (NASDAQ: CVAC) shares are trading higher after the company announced the appointment of Dr. Malte Greune as COO and the transition of Dr. Florian von der Mülbe to lead accelerated development of the RNA printer.
Why CureVac Shares Are Trading Lower Today
CureVac BV (NASDAQ: CVAC) shares are trading lower by 3.6% at $56 after the CDC said preliminary findings suggest the observed reports of heart inflammation after mRNA COVID-19 vaccines are greater than expected.
Europe Purchases Additional 150M Doses Of Moderna COVID-19 Vaccine
The European Union has decided to take up an option under a supply contract with Moderna Inc (NASDAQ:MRNA) that allows the bloc…
German Financial Watchdog Investigates Possible Insider Trading In Curevac Shares
- Reuters Citing Rheinische Post
58 Biggest Movers From Friday
Gainers
CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries.
32 Stocks Moving In Friday’s Mid-Day Session
Gainers
CAI International, Inc. (NYSE: CAI) shares jumped 46.4% to $55.86 after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.
CVAC Stock Price Increases 14%: Why It Happened
CureVac BV (NASDAQ: CVAC) shares are trading higher by 14% at $66.16 as the stock rebounds after falling in recent sessions.
Benzinga Pro’s Top 20 Searched Tickers In Benzinga Pro For Morning Of Friday, Jun. 18, 2021
Orphazyme (ORPH)
AMC Entertainment (AMC)
UTime (UTME)
Midatech Pharma (MTP)
Cellect Biotechnology (APOP)
KULR Technology Group (KULR)
Clearside Biomedical (CLSD)
Advanced Micro Devices (AMD)
CureVac